In a stark revelation about the increasing incidence of colorectal cancer in younger adults, the Canadian Cancer Society has urged provincial and territorial governments to lower the recommended screening age from 50 to 45. This call comes in light of alarming statistics indicating that individuals under 50 are now facing a higher risk of diagnosis than ever before. The plea for change is echoed by personal accounts, such as that of Michael Groves, who faced a life-altering diagnosis after being initially misdiagnosed.
A Personal Journey to Diagnosis
Michael Groves, a 54-year-old resident of Ottawa, experienced what he believed to be appendicitis in January 2021. After visiting the emergency department for abdominal discomfort, tests ruled out his initial fears, and he returned home. However, when he noticed blood in his stool days later, his family physician took precautionary measures and scheduled him for a colonoscopy in April.
“It never crossed my mind that it could be colon cancer,” Groves reflected in an interview. Unfortunately, the procedure revealed a shocking diagnosis: a five-centimetre tumour classified as Stage 3 colorectal cancer, which had already metastasised to two lymph nodes.
“The shock was just, like, wow, just devastating,” Groves recounted, highlighting his previous misconception of being in good health. Just days prior, he had completed a 5K run without any signs of illness.
The Case for Earlier Screening
Groves underwent surgery to remove a significant portion of his colon, followed by a challenging six-month chemotherapy regimen that kept him away from work for nearly nine months. He now advocates for routine screening for colorectal cancer to begin in the 40s, believing that earlier detection could have significantly altered his treatment experience.
His sentiments resonate with an increasing number of Canadians, as the Canadian Cancer Society reports a worrying trend: individuals under 50 are 2 to 2.5 times more likely to receive a colorectal cancer diagnosis compared to previous generations.
Brandon Purcell, advocacy manager for prevention and early detection at the Canadian Cancer Society, emphasised the urgency of this issue: “That growth is something that’s very concerning for us, and we think that it’s time for governments to react to that so we can catch more of these cancers early.”
Current Screening Protocols and Their Limitations
Currently, individuals aged 50 and older are advised to participate in routine screening through a fecal immunochemical test (FIT). This home-based test allows individuals to collect a stool sample and send it to a laboratory for analysis. If results indicate the presence of blood, a follow-up colonoscopy is arranged to identify potential malignancies.
However, those under 50 experiencing specific risk factors, such as a family history of colorectal cancer or symptoms like blood in the stool, may be referred for proactive colonoscopy. The Cancer Society argues that expanding the FIT programme to include those aged 45 and above would facilitate earlier cancer detection.
The survival rate for early-stage colorectal cancer can soar to 90 per cent, while advanced-stage diagnoses plummet to a mere 15 per cent. Additionally, colonoscopies serve a preventative role, as they can identify and remove precancerous polyps before they evolve into cancerous growths.
Supporting Evidence for a Policy Change
Both the Canadian Cancer Society and Colorectal Cancer Canada cite a recent modelling study published on March 7 in the Journal of the Canadian Association of Gastroenterology. This research posits that implementing home-based FIT testing starting at age 45 could prevent approximately 15,070 cases of colorectal cancer and avert 6,100 deaths over the next 45 years.
The study’s senior author, Darren Brenner, a professor at the University of Calgary, also highlighted the potential economic benefits, estimating a cost savings of $233 million in cancer treatments, even when factoring in the expenses associated with additional tests and procedures.
Why it Matters
The push to lower the colorectal cancer screening age is not merely a matter of statistics; it reflects a growing recognition of the shifting landscape of cancer diagnoses among younger populations. As more Canadians like Michael Groves emerge with similar experiences, the imperative for timely intervention becomes ever clearer. By taking proactive steps towards earlier screening, we can enhance survival rates and improve the quality of life for future generations, ensuring that no one has to endure the shock of a late-stage diagnosis when a simple test could have changed their fate.
